CORONAVIRUSPublished 2 days ago Coronavirus drug remdesivir gets conditional approval in Europe | BCRX Message Board Posts

BioCryst Pharmaceuticals Inc.

  BCRX website

  •  Registered Members of Investor Village:
    Please make sure you are signed in to your Investor Village account to enjoy the full benefits of our service and avoid the MediaPass paywall. If the MediaPass offer page is blocking you, click the light blue "No thanks, take me back" link on the middle right side of the form to get to our home page where you can sign in by entering your Investor Village User Name and Password. 

     MediaPass subscribers: Please make sure you are logged in to your MediaPass subscription to bypass the paywall. You can do this by clicking the light blue "Already have a MediaPass account? Login here" link on the middle left side of the subscription offer form and then entering the email address and password you used when you first signed up with MediaPass.  

    For assistance call 888-222-7309 or email admin@investorvillage.com

BCRX   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  12104 of 12156  at  6/27/2020 7:07:53 PM  by

frnktofini


CORONAVIRUSPublished 2 days ago Coronavirus drug remdesivir gets conditional approval in Europe

 Remdesivir, the much-talked-about experimental drug used to treat COVID-19 patients, has been conditionally approved by Europe's top health care regulator, becoming the first drug to be "recommended for authorization" on the continent.
 

The European Medicines Agency (EMA) said that its human medicines committee (CHMP) has recommended the drug, which will be known as Veklury, for treating COVID-19 "in adults and adolescents from 12 years of age with pneumonia who require supplemental oxygen," according to a statement on the EMA's website.

"Remdesivir is recommended for a conditional marketing authorization, one of the EU regulatory mechanisms to facilitate early access to medicines that fulfill an unmet medical need, including in emergency situations in response to public health threats such as the current pandemic," the EMA said in the statement.



     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 141
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...